Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v4-FR
Language French French
Date Updated 2018-07-05 2017-04-13
Drug Identification Number 02286335 02286335
Brand name MYLAN-ALENDRONATE MYLAN-ALENDRONATE
Common or Proper name ALENDRONATE ALENDRONATE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ALENDRONIC ACID ALENDRONIC ACID
Strength(s) 70MG 70MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 4 BL 4 BL
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-07-03 2017-09-25
Actual start date 2018-07-03
Estimated end date Unknown
Actual end date 2018-07-03 2017-04-11
Shortage status Resolved Avoided shortage
Tier 3 Status No No
Company comments Discontinued in ID 44751
Health Canada comments